The Price for Remdesivir

Gilead set the cost at $520 per dose in the United States

Gilead sets the pricing for remdesivir. The pharmaceutical company announced on Monday that it set pricing for its remdesivir treatment at $520 per dose in the United States. The company has been donating doses to the U.S. government since it received emergency use authorization in May.

Specifically, the company will sell remdesivir for $390 per vial to governments “of developed countries” around the world and the price for U.S. private insurance companies will stand…